Voxeleron Inc.

Computer vision and machine learning software for ophthalmic imaging.
Bluesky: @[email protected]

[Voxeleron Inc. @voxeleron]

New deep learning-based paper: Machine Learning Quantification of Fluid Volume in Eyes With Retinal Vein Occlusion Treated With Aflibercept
https://t.co/J0CmaSiouL

[Voxeleron Inc. @voxeleron]

New deep learning-based paper for the prediction of treatment response of diabetic macular edema to anti-VEGF
https://t.co/AZ3HUzDggh

[Voxeleron Inc. @voxeleron]

New deep learning-based paper for the automatic detection and classification of microaneurysms in OCT:
https://t.co/2kxDPOZsA9

[Voxeleron Inc. @voxeleron]

Stop by and see us at #ARVO2024! We are excited to share how iNebula is enabling quicker trial decisions with real-time access to imaging data! And read our pre-ARVO newsletter here: https://t.co/GpRYEmeUt4

[Voxeleron Inc. @voxeleron]

Dive into the success story of TI Image as they accelerated their expansion into ophthalmic clinical trials with Voxeleron's device-agnostic solutions! 🌟 Learn how seamless onboarding led to remarkable results. Read the full spotlight now! https://t.co/YAqTp2IVQR

[Voxeleron Inc. @voxeleron]

Just 1 day left until our webinar! Dive into the world of AI-based endpoints with Allgenesis Biotherapeutics, @LexitasPharma and Voxeleron. Register now for tomorrow's event at 12 pm PDT! #OphthalmicTrials
https://t.co/krn0uygwrZ

[Voxeleron Inc. @voxeleron]

Don't miss our upcoming webinar on April 9th, 12 pm PDT! Join us to explore how Allgenesis Biotherapeutics utilized AI-based endpoints to drive their Phase 2A DME study. Secure your spot today! #OphthalmicTrials #Webinar https://t.co/krn0uygwrZ

[Voxeleron Inc. @voxeleron]

Join our upcoming webinar to learn how Allgenesis Biotherapeutics evaluated AI-based endpoints to drive their Phase 2A DME study, in collaboration with @LexitasPharma and Voxeleron. Register now for our live event on April 9th, 12 pm PDT! https://t.co/krn0uygwrZ

[Voxeleron Inc. @voxeleron]

We're thrilled to announce Joanna Williams as our new CEO, bringing over 25 years of experience to Voxeleron. Joanna will be leading efforts to scale operations and explore new market opportunities. #HealthTech #AI #Ophthalmology
https://t.co/nlbsUJ8bSC

[Voxeleron Inc. @voxeleron]

We are thrilled to announce that Voxeleron has attained ISO 13485:2016 certification, a significant milestone complementing our existing SOC 2 certification, along with compliance to 21 CFR Part 11 and GDPR. Read our full announcement to learn more. https://t.co/EN9AZPpP6t

[Voxeleron Inc. @voxeleron]

Thank you to our customers, partners and colleagues for a great 2023. If you missed any of our posts or announcements over the past year, you can find them on our blog page. Wishing you a Happy New Year from all of us at Voxeleron! https://t.co/KEPm0fZiPT

[Voxeleron Inc. @voxeleron]

Happy holidays from the Voxeleron team! Wishing you and your loved ones a joyous holiday season.🎄

[Voxeleron Inc. @voxeleron]

Check out our latest iNebula software release featuring dynamically configurable workflows! Delivering a seamless experience while capturing any and all clinical trial scenarios. #HealthTech #ClinicalTrials #Ophthalmology https://t.co/LM6UsKyrCe

[Voxeleron Inc. @voxeleron]

What's next in HealthTech? Explore the emerging trends in patient data privacy, AI's role in Ophthalmology, and more in our latest blog recapping MedTech 2023. #HealthTech #MedTech2023 #Ophthalmology https://t.co/dpLbiyzDJE

[Voxeleron Inc. @voxeleron]

Exciting news! Voxeleron has partnered with Atherion Bioresearch, a leading CRO. Together, we offer a powerful platform for streamlined drug development. Learn more: https://t.co/WD0nB02RH5

[Voxeleron Inc. @voxeleron]

Did you miss our live webinar with Voiant? The on-demand version is now available. Dive into interoperability and AI-backed solutions. Watch now! #ophthamology
https://t.co/Z1jvlLbyXb

[Voxeleron Inc. @voxeleron]

Excited to present at @MedTechCon 2023! Catch Voxeleron at Innovation Pavilion on Wednesday 10/11 at 10:45 am PDT as we dive into the latest trends shaping the future of healthtech in ophthalmology. #Medtech2023 #ophthalmology
https://t.co/TGN63ZRTJ8

[Voxeleron Inc. @voxeleron]

T-minus 1 hour! Our webinar with Voiant discussing challenges and innovations in ophthalmic clinical trials is about to kick off. Dive into the world of interoperability and AI solutions. Last call to join the innovation journey! https://t.co/t3VLGeKL0S

[Voxeleron Inc. @voxeleron]

Reduce read times in your ophthalmic clinical trials! Don't miss our webinar with Voiant (formerly DARC) on Oct 5th at 1 pm ET. We'll tackle speed, interoperability, and game-changing AI solutions. Secure your spot now! #ClinicalTrials #Ophthalmology https://t.co/t3VLGeKL0S

[Voxeleron Inc. @voxeleron]

Ready to enhance the speed & efficiency of ophthalmic clinical trials? Join our webinar with Voiant (formerly DARC) to explore challenges & innovations in ophthalmic research. Learn why interoperability matters & preview AI-backed analysis. Register now!
https://t.co/t3VLGeKL0S